Author:
Harries Timothy H,Seed Paul T,Jones Simon,Schofield Peter,White Patrick
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine
Reference30 articles.
1. The Burden of Lung Disease. 2nd Edn. A Statistics report from the BTS.
http://www.brit-thoracic.org.uk/Portals/0/Library/BTS%20Publications/burdeon_of_lung_disease2007.pdf
, 2006.
2. NICE. CG101 Chronic obstructive pulmonary disease (update): NICE guideline. at
http://publications.nice.org.uk/chronic-obstructive-pulmonary-disease-cg101
.
3. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449–456.
4. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–789.
5. Wedzicha JA, Calverley PMA, Seemungal TA, Hagan G, Ansari Z, Stockley R . The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177: 19–26.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献